GSK360A (C008B-266919)

GSK360A is an active HIF-PHD inhibitor. GSK360A has systemic and local effects by stabilizing HIF-1α signaling and can improve long-term ventricular function.

a HIF-PHD inhibitor

Specifications & Purity: GSK360A is an active HIF-PHD inhibitor. GSK360A has systemic and local effects by stabilizing HIF-1α signaling and can improve long-term ventricular function.

Grade: Moligand™

Molecular Formula: C17H17FN2O5

Molecular Weight: 348.33

PubChem CID: 54685147

Isomeric SMILES: C1CC1CCN2C3=C(C=C(C=C3)F)C(=C(C2=O)C(=O)NCC(=O)O)O

Storage Temperature: Store at -20°C

Shipped in: Ice chest + Ice pads

More Information: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/G339111-SCI_f62b2c039a0fda3ee707f4bedfb7a734.pdf

UPC:

51373478

Weight:

1.09 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

G339111-100mg

Country of Origin:

China

CAS:

931399-19-8

Product Size:

100mg

Harmonized Tariff Code:

2931.90.90

Precautionary Statement Codes:

P264